Document is current
Any future updates will be listed below
-
Authors
Morita, Tomoko Yamamori
Yu, Jie http://orcid.org/0000-0003-4423-1778
Kashima, Yukie
Kamata, Ryo http://orcid.org/0000-0001-6970-9657
Yamamoto, Gaku
Minamide, Tatsunori
Mashima, Chiaki
Yoshiya, Miyuki
Sakae, Yuta
Yamauchi, Toyohiro
Hakozaki, Yumi
Kageyama, Shun-ichiro http://orcid.org/0000-0002-6072-0144
Nakamura, Akito
Lightcap, Eric http://orcid.org/0000-0003-4825-3595
Tanaka, Kosuke
Niu, Huifeng
Kannan, Karuppiah
Ohashi, Akihiro http://orcid.org/0000-0002-4036-9385
- License Information
-
More Information
Article History
Received: 22 August 2022
Accepted: 6 November 2023
First Online: 18 November 2023
Competing interests
: J.Y., A.N., E.L., H.N., K.K., and A.O. are/were employees of Takeda Pharmaceutical Company, Ltd. A.O. is a part-time employee of Astellas Pharma Inc. as a cross-appointment system. A.O. reported paid consulting or advisory roles for Ono Pharmaceutical Company Ltd., Craif Inc., and GEXVal Inc. out of this study. A.O. has received research funding from Daiichi-Sankyo and Astellas Pharma out of this study. The remaining authors declare no competing interests.
